AURA250117P7500
- 0.35
- 0.000.00%
Aura Biosciences Newsroom
LifeSci Capital Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $23
BTIG Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $24
Scotiabank Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $23
A Quick Look at Today's Ratings for Aura Biosciences(AURA.US), With a Forecast Between $20 to $24
Aura Biosciences Analyst Ratings
TD Cowen Maintains Aura Biosciences(AURA.US) With Buy Rating
LifeSci Capital Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $23
Buy Rating for Aura Biosciences Inc Driven by Promising Clinical Progress and Strategic Growth
A Quick Look at Today's Ratings for Aura Biosciences(AURA.US), With a Forecast Between $20 to $24
A Quick Look at Today's Ratings for Aura Biosciences(AURA.US), With a Forecast Between $22 to $24
Aura Biosciences Is Maintained at Buy by HC Wainwright & Co.
Aura Biosciences Analyst Ratings
Promising Early Clinical Data and Dual Mechanism Boost Aura Biosciences' Buy Rating
LifeSci Capital Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $23
Evercore Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $20
LifeSci Capital首予Aura Biosciences(AURA.US)买入评级，目标价23美元
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), Aura Biosciences Inc (AURA)
JMP Securities Maintains Aura Biosciences(AURA.US) With Buy Rating, Maintains Target Price $23
Aura Biosciences Inc's Promising Clinical Trial Results Bolster Buy Rating
Evercore ISI Sticks to Its Buy Rating for Aura Biosciences Inc (AURA)